| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/17/1994 | US5312825 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity |
| 05/17/1994 | US5312824 Certain 2-[(4-difluoromethoxy-2-pyridyl)-methylthio or methylsulfinyl-5-benzimidazoles useful for treating peptic ulcers |
| 05/17/1994 | US5312823 7-azaisoindolinyl-quinolone-carboxylic acid derivatives |
| 05/17/1994 | US5312821 Antiulcer agents |
| 05/17/1994 | US5312819 Schizophrenia |
| 05/17/1994 | US5312818 (Interphenylene)7-oxabicycloheptane substituted (di)amide prostaglandin analog |
| 05/17/1994 | US5312817 Treatment of fatigue syndrome |
| 05/17/1994 | US5312816 Method of combatting osteoporosis in mammalian subjects, utilizing organic boron compounds |
| 05/17/1994 | US5312815 Fungicidal (+)-2-(2,4-difluorophenyl)-3-methyl-1-(1H-1,2,4-triazol-1-yl)3-(6-(1H-1,2,4-triazol-1-yl)pyridazin-3-ylthio) butan-2-ol |
| 05/17/1994 | US5312814 α-phosphonocarboxylate squalene synthetase inhibitors |
| 05/17/1994 | US5312792 Catalytic compositions |
| 05/17/1994 | US5312629 Method for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases |
| 05/17/1994 | US5312626 Lozenge or chewable tablet |
| 05/17/1994 | US5312625 Fused 7-membered cyclic compound and antipsychotic preparation containing the same |
| 05/17/1994 | CA2088436A1 Nitrogen bridge tetrahydroisoquinolines |
| 05/17/1994 | CA1329680C N-heterocyclic alcohol derivatives |
| 05/17/1994 | CA1329621C Naphthoquinones in the treatment or prophylaxis of pneumocystis carinii infections |
| 05/17/1994 | CA1329620C Ethynylphenyl-containing retinoic acid derivatives |
| 05/17/1994 | CA1329618C Aminoalkyl-substituted heterocyclic sulfur compounds |
| 05/17/1994 | CA1329617C Resolved amino pyrrolidine neuroprotective agents |
| 05/17/1994 | CA1329616C Aromatase inhibiting 4(5)-imidazoles |
| 05/17/1994 | CA1329611C Substituted 1,3,4,9-tetrahydropyrano [3,4-b]indole-1-acetic acids |
| 05/17/1994 | CA1329609C Araliphatylaminoalkanediphosphonic acids |
| 05/17/1994 | CA1329605C Antidepressant n-substituted nicotinamide compounds |
| 05/17/1994 | CA1329604C Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained therein, and processes for the preparation of these heterocyclic compounds |
| 05/17/1994 | CA1329603C 2,2-dimethylchromene derivatives, process for their preparation and pharmaceutical compositions in which they are present |
| 05/17/1994 | CA1329602C Condensation products of 2,2,4-trimethyl-1,2-dihydro- quinoline and oxo compounds and derivatives thereof |
| 05/17/1994 | CA1329601C Cardiotonic tricyclic oxazolones |
| 05/17/1994 | CA1329600C 1,4-dihydropyridines |
| 05/17/1994 | CA1329598C Retinoid carboxylic esters |
| 05/17/1994 | CA1329597C Derivatives of tetrahydropyrido[1,2-a]indole |
| 05/17/1994 | CA1329594C 5-(substituted)amino)-8-(phenyl or substituted phenyl)-3h,6h-1,4,5a,8a-tetraazaacenaphthyen-3-ones |
| 05/17/1994 | CA1329591C Pharmaceutical products and new lactosyl compounds and the preparation thereof |
| 05/17/1994 | CA1329589C Seco-sterol compounds, effective in inducing cell differentiation |
| 05/17/1994 | CA1329553C Pharmaceutical preparations |
| 05/17/1994 | CA1329550C Non-.beta.-oxidizable fatty acid analogues with the effect to reduce the concentration of cholesterol and triglyoerides in blood of mammals |
| 05/17/1994 | CA1329549C Microparticles containing an antimalarial active ingredient |
| 05/17/1994 | CA1329547C Skin permeation enhancer compositions using glycerol monooleate |
| 05/15/1994 | CA2538177A1 Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds |
| 05/15/1994 | CA2504502A1 Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds |
| 05/13/1994 | CA2108609A1 Cephalosporin derivatives |
| 05/11/1994 | WO1994010323A1 Virus with modified binding moiety specific for the target cells |
| 05/11/1994 | WO1994010314A1 Allergenic proteins and peptides from johnson grass pollen |
| 05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
| 05/11/1994 | WO1994010307A1 Transcription factor dp-1 |
| 05/11/1994 | WO1994010301A1 TNF-α RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-α RIBOZYMES |
| 05/11/1994 | WO1994010193A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 05/11/1994 | WO1994010190A1 6,7α-DIFLUOROMETHYLENANDROSTA-1,4-DIEN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
| 05/11/1994 | WO1994010178A1 6-(substituted methylene) penems and intermediates |
| 05/11/1994 | WO1994010177A1 Cephem compounds, and their pharmaceutical compositions |
| 05/11/1994 | WO1994010176A1 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents |
| 05/11/1994 | WO1994010175A1 Topoisomerase ii inhibitors and therapeutic uses therefor |
| 05/11/1994 | WO1994010174A1 Piperidine derivatives as 5-ht4 receptor antagonists |
| 05/11/1994 | WO1994010172A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 05/11/1994 | WO1994010171A1 5-arylindole derivatives and their use as serotonin (5-ht1) agonists |
| 05/11/1994 | WO1994010170A1 Substituted quinuclidines as substance p antagonists |
| 05/11/1994 | WO1994010169A1 Method for preparing taxane derivatives |
| 05/11/1994 | WO1994010166A1 Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds |
| 05/11/1994 | WO1994010165A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 05/11/1994 | WO1994010164A1 4-quinolinyl derivatives with anti-helicobacter activity |
| 05/11/1994 | WO1994010163A1 Antimicrobial 5-hydrazino-quinolone derivatives |
| 05/11/1994 | WO1994010162A1 Dopamine receptor subtype ligands |
| 05/11/1994 | WO1994010161A1 1,3-dioxane derivatives having protein kinase c inhibitory activity |
| 05/11/1994 | WO1994010157A1 Styrene derivative and salts thereof |
| 05/11/1994 | WO1994010151A1 Substituted phthalazinones as nerotensin antagonists |
| 05/11/1994 | WO1994010150A1 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aβ)-6-ISOQUINOLINEAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF |
| 05/11/1994 | WO1994010148A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
| 05/11/1994 | WO1994010146A1 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists |
| 05/11/1994 | WO1994010145A1 Dopamine receptor subtype ligands |
| 05/11/1994 | WO1994010144A1 Indolylcarbamates as anti-inflammatory agents |
| 05/11/1994 | WO1994010143A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 05/11/1994 | WO1994010142A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 05/11/1994 | WO1994010141A1 Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or arylaliphatic derivatives and homologous |
| 05/11/1994 | WO1994010140A1 High purity beta-carotene |
| 05/11/1994 | WO1994010139A1 Novel vitamin d analogues |
| 05/11/1994 | WO1994010138A1 Inhibitors of farnesyl-protein transferase |
| 05/11/1994 | WO1994010136A1 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors |
| 05/11/1994 | WO1994010135A1 Benzenesulfonamide derivative |
| 05/11/1994 | WO1994010134A1 Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 05/11/1994 | WO1994010129A1 Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it |
| 05/11/1994 | WO1994010127A1 Tartronic acids, their acetalic ethers and o-esters |
| 05/11/1994 | WO1994010118A1 Tri-substituted phenyl derivatives and processes for their preparation |
| 05/11/1994 | WO1994009808A1 Substances having the growth-promoting effect of amyloid precursor protein |
| 05/11/1994 | WO1994009801A1 Free active oxygen radical scavenger |
| 05/11/1994 | WO1994009797A1 Compound for the biological stimulation and correction of the phenotype of an organism and a process for producing the same |
| 05/11/1994 | WO1994009796A1 Buffered diaper rash cream |
| 05/11/1994 | WO1994009795A1 Bimodal molecular weight hyaluronate formulations and methods for using same |
| 05/11/1994 | WO1994009794A1 Ophthalmic solution and method of use |
| 05/11/1994 | WO1994009793A1 ENANTIOMERICALLY PURE β-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY |
| 05/11/1994 | WO1994009792A1 Small molecule inhibition of rna/ligand binding |
| 05/11/1994 | WO1994009791A1 Fludarabine-5'-monophosphate for the treatment of autoimmune diseases |
| 05/11/1994 | WO1994009790A1 The use of inositoltrisphosphate for the preparation of medicaments |
| 05/11/1994 | WO1994009789A1 USE OF 17α-DIHYDROEQUILENIN FOR LOWERING CHOLESTEROL |
| 05/11/1994 | WO1994009788A1 Cyclopentane heptenylsulfinylalkyl and heptanylsulfinylalkyl-2-aliphatic or aryl aliphatic derivatives |
| 05/11/1994 | WO1994009787A1 Synergistic combination for the therapy of degenerative ageing diseases containing an adenosine antagonist and a cholinomimetic |
| 05/11/1994 | WO1994009786A1 Methods and compositions of (+) doxazosin for the treatment of hypertension |
| 05/11/1994 | WO1994009785A2 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
| 05/11/1994 | WO1994009784A1 Platelet aggregation inhibitor |
| 05/11/1994 | WO1994009783A1 Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
| 05/11/1994 | WO1994009782A1 Methods and compositions of (-) doxazosin for the treatment of hypertension |